(Q37981641)

26 August 2017

Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics? (English)

1 reference

26 August 2017

1 reference

Demosthenes G Katritsis

series ordinal

1

1 reference

PubMed ID

22308081

26 August 2017

Mark E Josephson

series ordinal

2

1 reference

PubMed ID

22308081

26 August 2017

language of work or name

1 reference

2 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

6

1 reference

26 August 2017

787-794

1 reference

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Regional variation in out-of-hospital cardiac arrest incidence and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Ventricular tachyarrhythmias after cardiac arrest in public versus at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden death after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Time in recurrent ventricular fibrillation and survival after out-of-hospital cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Evidence-based medicine and the implantable defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Time dependence of mortality risk and defibrillator benefit after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Home use of automated external defibrillators for sudden cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden cardiac arrest without overt heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Postmortem molecular screening in unexplained sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden coronary death in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The cost of implantable defibrillators: perceptions and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The high cost of implantable defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Medical economics and the assessment of value in cardiovascular medicine: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Medical economics and the assessment of value in cardiovascular medicine: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The cost of implantable defibrillators: how the perception of reality depends on perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Cost-effectiveness of implantable cardioverter-defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Defibrillator implantation early after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUS001

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUS001

1 reference

26 August 2017

1 reference

PubMed ID

22308081